Home
Storia in 2 fonti
Aurobindo Pharma’s Q4 net up 2% to ₹921 crore
Aurobindo Pharma reports a 2% net profit rise to ₹921 crore with total revenue growing 5.6% to ₹8,853 crore in Q4.
- ·
thehindubusinessline.com
Aurobindo Pharma’s Q4 net up 2% to ₹921 crore
Aurobindo Pharma reports a 2% net profit rise to ₹921 crore with total revenue growing 5.6% to ₹8,853 crore in Q4.
- ·
thehindu.com
Aurobindo Pharma Q4 net up 2% to ₹921 cr
Aurobindo Pharma reports Q4 net profit rise to ₹921 crore, driven by strong European market performance and overall revenue growth.
- ·
Aurobindo Pharma edges past Dr Reddy’s in FY26 revenue race
Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.